cgrp inhibitors
Treatment for Cluster Headache
CGRP inhibitors are monoclonal antibodies that block the calcitonin gene-related peptide (CGRP) receptor or ligand, preventing CGRP-mediated vasodilation and neurogenic inflammation associated with cluster headaches. By interrupting this neuropeptide's signaling pathway, these medications reduce the frequency and severity of cluster headache attacks, offering a targeted therapeutic approach to managing this severe neurological condition.